Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study

/PRNewswire/ -- Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict...

Related Keywords

Ridgefield ,Pennsylvania ,United States ,Germany ,Philadelphia ,American ,Mohamed Eid ,Prnewswire Boehringer Ingelheim ,Navdeep Tangri ,Mark Cziraky ,Elevance Health ,Carelon Research ,Boehringer Ingelheim Pharmaceuticals Inc ,Boehringer Ingelheim ,Clinical Development Medical Affairs ,Animal Health ,American Society Of Nephrology ,American Society ,Kidney Week ,Clinical Development ,Medical Affairs ,Respiratory Medicine ,Boehringer Ingelheim Pharmaceuticals ,Human Pharma ,Corporate Headquarters ,Ingelheim Pharmaceuticals ,Nc ,